These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17085996)

  • 1. Solodyn (Minocycline HCl, USP) extended-release tablets.
    Gupta AK; Gover MD; Abramovits W; Perlmutter A
    Skinmed; 2006; 5(6):291-2. PubMed ID: 17085996
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic Comparison of Once-Daily Topical Minocycline Foam 4% vs Oral Minocycline for Moderate-to-Severe Acne.
    Jones TM; Ellman H; deVries T
    J Drugs Dermatol; 2017 Oct; 16(10):1022-1028. PubMed ID: 29036256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-release minocycline (Solodyn) for acne.
    Med Lett Drugs Ther; 2006 Nov; 48(1248):95-6. PubMed ID: 17106435
    [No Abstract]   [Full Text] [Related]  

  • 4. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
    Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
    J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amzeeq (minocycline foam 4%) for topical treatment of acne vulgaris.
    Gupta AK; Bruce A; Vincent KD; Abramovits W
    Skinmed; 2020; 18(6):354-357. PubMed ID: 33397564
    [No Abstract]   [Full Text] [Related]  

  • 6. Minocycline foam (Amzeeq) for acne.
    Med Lett Drugs Ther; 2020 May; 62(1597):68-70. PubMed ID: 32555112
    [No Abstract]   [Full Text] [Related]  

  • 7. Dose-ranging efficacy of new once-daily extended-release minocycline for acne vulgaris.
    Stewart DM; Torok HM; Weiss JS; Plott RT;
    Cutis; 2006 Oct; 78(4 Suppl):11-20. PubMed ID: 17436825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minocycline-induced pigmentation of the skin and nails.
    Ali FR; Yiu ZZ; Ogden S
    Postgrad Med J; 2015 Nov; 91(1081):662. PubMed ID: 26500011
    [No Abstract]   [Full Text] [Related]  

  • 9. Azithromycin compared with minocycline in the treatment of acne comedonica and papulo-pustulosa.
    Gruber F; Grubisić-Greblo H; Kastelan M; Brajac I; Lenković M; Zamolo G
    J Chemother; 1998 Dec; 10(6):469-73. PubMed ID: 9876055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of a new extended-release formulation of minocycline.
    Fleischer AB; Dinehart S; Stough D; Plott RT; ;
    Cutis; 2006 Oct; 78(4 Suppl):21-31. PubMed ID: 17436826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit-risk assessment of acne therapies.
    Seukeran DC; Eady EA; Cunliffe WJ
    Lancet; 1997 Apr; 349(9060):1251-2. PubMed ID: 9130967
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperthyroidism and lupus-like syndrome in an adolescent treated with minocycline for acne vulgaris.
    Benjamin RW; Calikoglu AS
    Pediatr Dermatol; 2007; 24(3):246-9. PubMed ID: 17542873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapsing acute respiratory failure induced by minocycline.
    Oddo M; Liaudet L; Lepori M; Broccard AF; Schaller MD
    Chest; 2003 Jun; 123(6):2146-8. PubMed ID: 12796202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minocycline-induced hyperpigmentation.
    Jung Kim S; English JC
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):77-8. PubMed ID: 22319793
    [No Abstract]   [Full Text] [Related]  

  • 15. [Minocycline in Acne--an autoimmune disease-like syndrome as a side effect].
    Jagusch W; Gruppe W
    Hautarzt; 1996 Dec; 47(12):936. PubMed ID: 9081943
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical minocycline foam for moderate to severe acne vulgaris: Phase 2 randomized double-blind, vehicle-controlled study results.
    Shemer A; Shiri J; Mashiah J; Farhi R; Gupta AK
    J Am Acad Dermatol; 2016 Jun; 74(6):1251-2. PubMed ID: 27185426
    [No Abstract]   [Full Text] [Related]  

  • 17. Key bioavailability features of a new extended-release formulation of minocycline hydrochloride tablets.
    Plott RT; Wortzman MS
    Cutis; 2006 Oct; 78(4 Suppl):6-10. PubMed ID: 17436824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy and safety of lymecycline and minocycline in patients with moderately severe acne vulgaris.
    Grosshans E; Belaïch S; Meynadier J; Alirezai M; Thomas L
    Eur J Dermatol; 1998; 8(3):161-6. PubMed ID: 9649660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minocycline in acne is still an issue.
    Corona R
    Arch Dermatol; 2000 Sep; 136(9):1143-5. PubMed ID: 10987872
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute hepatitis and minocycline].
    Real Martínez Y; Medina S
    Rev Esp Enferm Dig; 2003 Oct; 95(10):741-2. PubMed ID: 14588070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.